BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 28975980)

  • 1. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
    Wei GH; Wang X
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3850-3856. PubMed ID: 28975980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
    Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
    Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
    Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
    Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
    Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
    Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer.
    Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
    Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide promotes the proliferation inhibition of mouse ovarian granulosa cells and premature ovarian failure by activating the lncRNA-Meg3-p53-p66Shc pathway.
    Xiong Y; Liu T; Wang S; Chi H; Chen C; Zheng J
    Gene; 2017 Jan; 596():1-8. PubMed ID: 27729272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
    Zhao JH; Sun JX; Song YX; Chen XW; Yang YC; Ma B; Wang J; Gao P; Wang ZN
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):601-9. PubMed ID: 26537802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression.
    Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R
    J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
    Dong X; Wang J; Li T; Xu YP; Li SY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MEG3 has anti-activity effects of cervical cancer.
    Wang X; Wang Z; Wang J; Wang Y; Liu L; Xu X
    Biomed Pharmacother; 2017 Oct; 94():636-643. PubMed ID: 28787698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer.
    Ding L; Tian Y; Wang L; Bi M; Teng D; Hong S
    Aging (Albany NY); 2019 Oct; 11(19):8139-8155. PubMed ID: 31584879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MEG3 mediated angiogenesis after cerebral infarction through regulating p53/NOX4 axis.
    Zhan R; Xu K; Pan J; Xu Q; Xu S; Shen J
    Biochem Biophys Res Commun; 2017 Aug; 490(3):700-706. PubMed ID: 28634073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer.
    Fu JW; Kong Y; Sun X
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1571-9. PubMed ID: 27095450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein.
    Liu Y; Yin L; Chen C; Zhang X; Wang S
    Dig Liver Dis; 2020 Mar; 52(3):331-338. PubMed ID: 31530437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c.
    Zhou X; Chen H; Zhu L; Hao B; Zhang W; Hua J; Gu H; Jin W; Zhang G
    Oncotarget; 2016 Dec; 7(50):82770-82782. PubMed ID: 27835575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression.
    Wang MW; Liu J; Liu Q; Xu QH; Li TF; Jin S; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4613-4622. PubMed ID: 29131253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.